Search Within

David Hyman

  1. "Breast Medicine Service"
Formats
  1. Journal Article (50)
  2. Meeting Abstract (33)
  3. Research Letter (3)
  4. Review (1)
Groups
  1. Breast Medicine Service (87)
  2. Department of Medicine (87)
  3. Early Drug Development Service (87)
  4. Solid Tumor Oncology Division (87)
  5. GSK Faculty (79)
  6. Human Oncology and Pathogenesis Program (72)

More Groups

People
  1. Michael Berger (51)
  2. David Solit (50)
  3. Ahmet Zehir (37)
  4. Jose Baselga (36)
  5. Marc Ladanyi (36)
  6. Mark Robson (31)

More People

Years
  1. 2021 (5)
  2. 2020 (16)
  3. 2019 (20)
  4. 2018 (13)
  5. 2017 (15)
  6. 2016 (7)

More Years

Publications
  1. Cancer Research (15)
  2. Journal of Clinical Oncology (14)
  3. Cancer Discovery (7)
  4. Clinical Cancer Research (7)
  5. JCO Precision Oncology (6)
  6. Blood (5)

More Publications

Publishers
  1. American Association for Cancer Research (29)
  2. American Society of Clinical Oncology (20)
  3. Nature Publishing Group (12)
  4. American Society of Hematology (5)
  5. American Medical Association (4)
  6. Cell Press (4)

More Publishers

Results (87)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Extreme outlier analysis identifies occult mitogen-activated protein kinase pathway mutations in patients with low-grade serous ovarian cancer
    Journal Article

    Grisham, R. N.; Sylvester, B. E.; Won, H.; McDermott, G.; DeLair, D.; Ramirez, R.; Yao, Z.; Shen, R. L.; Dao, F.; Bogomolniy, F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Diverse kinase mutations and fusions drive non-Langerhans cell histiocytoses
    Meeting Abstract

    Durham, B.; Diamond, E.; Yao, Z.; Ma, J.; Choi, J.; Kim, E.; Lee, S.; Gao, Y.; Micol, J. B.; Campbell, P.; more...
    Pediatric Blood and Cancer (2015)

    Fulltext@MSK | Save
  • Tumor relevant germline findings in targeted tumor sequencing using matched normal DNA of 1,570 unselected cases
    Meeting Abstract

    Schrader, K. A.; Cheng, D. T.; Vijai, J.; Prasad, M.; Walsh, M.; Zehir, A.; Thomas, T.; Benayed, R.; Stadler, Z. K.; Ashraf, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • The clinical utility of ERBB2 amplification detection in breast carcinoma using a 341 gene hybrid capture-based next generation sequencing (NGS) assay: Comparison with standard immunohistochemistry (IHC) and Fluorescence In Situ Hybridization (FISH) assays
    Meeting Abstract

    Ross, D. S.; Zehir, A.; Cheng, D. T.; Nafa, K.; Jour, G.; Razavi, P.; Hyman, D. M.; Baselga, J.; Berger, M. F.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I trial of the HSP-90 inhibitor PU-H71
    Meeting Abstract

    Gerecitano, J. F.; Modi, S.; Rampal, R.; Drilon, A. E.; Fury, M. G.; Gounder, M. M.; Harding, J. J.; Hyman, D. M.; Varghese, A. M.; Voss, M. H.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Prospective blinded study of BRAFV600E mutation detection in cell-free DNA of patients with systemic histiocytic disorders
    Journal Article

    Hyman, D. M.; Diamond, E. L.; Vibat, C. R. T.; Hassaine, L.; Poole, J. C.; Patel, M.; Holley, V. R.; Cabrilo, G.; Lu, T. T.; Arcila, M. E.; more...
    Cancer Discovery (2015)

    Fulltext@MSK | Save
  • ABT-888 plus bendamustine is safe and has shown preliminary efficacy in patients with lymphoma
    Meeting Abstract

    Gerecitano, J. F.; Schwartz, G. K.; Carvajal, R.; Fury, M.; Konner, J.; Hyman, D. M.; Gounder, M.; Gajria, D.; Teitcher, J.; Zhang, Z.; more...
    Blood (2013)

    Fulltext@MSK | Save